0000932440-17-000088.txt : 20171129 0000932440-17-000088.hdr.sgml : 20171129 20171129170702 ACCESSION NUMBER: 0000932440-17-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171127 FILED AS OF DATE: 20171129 DATE AS OF CHANGE: 20171129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHREIBER ALAIN CENTRAL INDEX KEY: 0001225149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 171229120 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ProQuest Associates IV LLC CENTRAL INDEX KEY: 0001431819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 171229122 BUSINESS ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 BUSINESS PHONE: 609-919-3567 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ProQuest Investments IV, L.P. CENTRAL INDEX KEY: 0001431818 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 171229123 BUSINESS ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 BUSINESS PHONE: 609-919-3567 MAIL ADDRESS: STREET 1: 2430 VANDERBILT BEACH ROAD STREET 2: #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moorin Jay CENTRAL INDEX KEY: 0001033508 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 171229121 MAIL ADDRESS: STREET 1: C/O PROQUEST INVESTMENTS, L.P STREET 2: 2430 VANDERBILT BEACH ROAD, #108 - 190 CITY: NAPLES STATE: FL ZIP: 34109 FORMER NAME: FORMER CONFORMED NAME: MOORIN JAY DATE OF NAME CHANGE: 19970213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-11-27 1 0001668243 UroGen Pharma Ltd. URGN 0001431818 ProQuest Investments IV, L.P. 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001431819 ProQuest Associates IV LLC 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001033508 Moorin Jay C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 0001225149 SCHREIBER ALAIN C/O PROQUEST INVESTMENTS 2430 VANDERBILT BEACH ROAD, #108 - 190 NAPLES FL 34109 0 0 1 0 Ordinary Shares, par value NIS 0.01 per share 2017-11-27 4 S 0 31491 41.12 D 1419838 D Ordinary Shares, par value NIS 0.01 per share 2017-11-28 4 S 0 177807 40.51 D 1242031 D The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares. Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $41.00 to $41.68. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction. Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $40.50 to $41.01. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction. /s/ Pasquale DeAngelis 2017-11-29